The global hemostasis and tissue sealing agents market is anticipated to grow at a CAGR of 9.3% during the forecast period (2023-2030). The treatment of chronic diseases leads to in the patient undergoing surgery, which drive the market growth. Urological disorders, Hernia fixation, spinal injuries, diabetes, burns, and ophthalmic injuries and replacements, are a few chronic conditions requiring these products. According to the WHO, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year. Further, United Spinal Association, in July 2022, every year approximately 17,700 Americans acquire a spinal cord injury. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happen because of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgery (4.3%). As per the American Academy of Ophthalmology Study 2023, a new study found that hospitalizations of people who had eye trauma rose by 18% over 13 years. Most of the increase was due to falls among people over age 65.
Owing to these factors, the manufacturers are compelled to develop the products o cater the market growth. In December 2019, Johnson & Johnson Medical Devices Companies Ethicon, Inc., launched the VISTASEAL™ Fibrin Sealant (Human) to manage bleeding during surgery. VISTASEAL Fibrin Sealant (Human) contains a combination of fibrinogen and thrombin, clotting proteins found in human plasma. When applied to the bleeding site, it forms a rapid, adherent, and durable clot and has been demonstrated to sustain hemostasis, even in high-risk patients. In three randomized controlled trials, VISTASEAL was associated with a lower overall hemostatic retreatment rate (0.9%-7.8%) compared to standard treatments (8.0%-16.7%).
To Request a Sample of our Report on Hemostasis and Tissue Sealing Agents Market: https://www.omrglobal.com/request-sample/hemostasis-and-tissue-sealing-agents-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Product
- By Material
- By Application
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- includes Baxter International, Inc., Becton, Dickinson & Co., Johnson & Johnson Medical NV, Medtronic Plc., Pfizer, Inc., and others.
Hemostasis and Tissue Sealing Agents Market Report Segment
By Product
- Topical Hemostat
- Adhesive and Tissue Sealant
By Material
- Collagen-based Topical Hemostats
- Gelatin based Topical Hemostats
- ORC-based Topical Hemostats
- Polysaccharide based Topical Hemostats
By Application
- General Surgery
- Minimally Invasive Surgery
- Trauma
- Other Applications (Hemophilia)
By End-User
- Hospitals
- Ambulatory Surgical Centers
A full Report of Hemostasis and Tissue Sealing Agents Market is Available @ https://www.omrglobal.com/industry-reports/hemostasis-and-tissue-sealing-agents-market
Hemostasis and Tissue Sealing Agents Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Advance Medical Solution Group Plc
- Artivion, Inc.,
- B Braun Holding GmbH & Co. KG
- Biomet Inc
- BioSpace, Inc.
- Cohera Medical Inc.,
- Covidien Plc
- Cryolife Inc.,
- Ethicon LLC
- Hyperbranch Medical Technology
- Integra Lifesciences Corp.,
- Issuu Inc.,
- Smith & Nephew plc,
- Terumo Corp.,
- Teleflex Inc.,
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hemostasis-and-tissue-sealing-agents-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404